Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg

GURNEE, Ill., Aug. 16, 2022 -- (Healthcare Sales & Marketing Network) -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic version of Cetrorelix Acetate for Injection, 0.25 mg (Cetroreli... Biopharmaceuticals, Generics, FDA Akorn, Cetrorelix, Cetrotide
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news